Search results
Results from the WOW.Com Content Network
Para-aminohippurate (PAH) clearance is a method used in renal physiology to measure renal plasma flow, which is a measure of renal function. [citation needed]PAH is completely removed from blood that passes through the kidneys (PAH undergoes both glomerular filtration and tubular secretion), and therefore the rate at which the kidneys can clear PAH from the blood reflects total renal plasma flow.
Blood tests for monitoring could be performed if you already have a diagnosis and your physician wants to make sure the treatments are working and to check for any negative side effects, Vasagar said.
Flow-through tests or immunoconcentration assays [1] are a type of diagnostic assay that allows users to test for the presence of a biomarker, usually a specific antibody, in a sample such as blood. They are a type of point of care test, designed to be used by a healthcare provider at patient contact. Point of care tests often allow for rapid ...
Blood tests are also used to assess kidney function. These include tests that are intended to directly measure the function of the kidneys, as well as tests that assess the function of the kidneys by looking for evidence of problems associated with abnormal function. One of the measures of kidney function is the glomerular filtration rate (GFR).
The kidney has many functions, which a well-functioning kidney realizes by filtering blood in a process known as glomerular filtration. A major measure of kidney function is the glomerular filtration rate (GFR). The glomerular filtration rate is the flow rate of filtered fluid through the kidney.
In medicine, Allen's test or the Allen test is a medical sign used in physical examination of arterial blood flow to the hands. It was named for Edgar Van Nuys Allen , who described the original version of the test in 1942.
Editor’s note: Before beginning any new exercise program, consult your doctor.Stop immediately if you experience pain. As you head into the gym, you likely already have a workout plan in mind ...
The former CEO of Abercrombie & Fitch (A&F) has dementia and late onset Alzheimer's disease, his legal team has said in a court document filed in New York. Lawyers for Mike Jeffries have requested ...